Gerard P Norton

September 18, 2017 | New Jersey Law Journal

On June 12, the U.S. Supreme Court issued a unanimous opinion in 'Sandoz v. Amgen,' a highly anticipated case concerning key provisions of the Biologics Price Competition and Innovation Act, part of the larger Patient Protection and Affordable Care Act of 2009.

By Gerard P. Norton and Michael S. Montgomery

7 minute read

March 27, 2017 | National Law Journal

Companies aiming to market generic versions of biopharmaceuticals now have details on how to qualify.

By Gerard P. Norton And Michael S. MontGomery

10 minute read

November 25, 2015 | New Jersey Law Journal

The Third Circuit adopts a rule of reason analysis in litigations involving reverse payment.

By Gerard P. Norton and Jin Zhu

8 minute read

November 25, 2015 | New Jersey Law Journal

The Third Circuit adopts a rule of reason analysis in litigations involving reverse payment.

By Gerard P. Norton and Jin Zhu

8 minute read

September 08, 2015 | New Jersey Law Journal

Two of the most powerful universities in the U.S. are engaged in a war over the basic patent for CRISPR gene-editing technology.

By Gerard P. Norton, Ph.D., and Jianming Jimmy Hao, Ph.D.

7 minute read

September 08, 2015 | New Jersey Law Journal

Two of the most powerful universities in the U.S. are engaged in a war over the basic patent for CRISPR gene-editing technology.

By By Gerard P. Norton, Ph.D., and Jianming Jimmy Hao, Ph.D.

7 minute read

January 22, 2007 | National Law Journal

Is there too much protectionism for patents and insufficient competition? This challenge emerges as a battle between two giant forces behind the American economic engine. KSR International Co. v. Teleflex Inc. and Technology Holding Co., No. 04-1350.

By Gerard P. Norton, Gerald Bilottto and Shahnam Sharareh/Special to The National Law Journal

12 minute read

January 02, 2013 | New Jersey Law Journal

On March 16, the U.S. patent system will change from a "first-to-invent" to a "first-to-file" system under the Leahy-Smith America Invents Act (AIA). This will trigger a race to the USPTO with every new idea and invention. The new norm for inventors will be to file early and file often. Along with this new norm, will come many traps, new and old, for the unwary.

By J. Jimmy Hao and Gerard P. Norton

8 minute read

December 27, 2006 | National Law Journal

On Nov. 28, a showdown took place before the U.S. Supreme Court over the point at which an invention is obvious -- and therefore unpatentable. At stake in KSR International Co. v. Teleflex Inc. is the current standard: whether a person of ordinary skill in the art at the time of the invention would have considered the new combination of elements obvious. Attorneys Shahnam Sharareh, Gerard Bilotto, Jonathan R. Lagarenne and Gerard P. Norton of New Jersey's Fox Rothschild give their take on the case.

By Shahnam Sharareh, Gerard Bilotto, Jonathan R. Lagarenne and Gerard P. Norton

5 minute read

December 27, 2006 | Law.com

On Nov. 28, a showdown took place before the U.S. Supreme Court over the point at which an invention is obvious -- and therefore unpatentable. At stake in KSR International Co. v. Teleflex Inc. is the current standard: whether a person of ordinary skill in the art at the time of the invention would have considered the new combination of elements obvious. Attorneys Shahnam Sharareh, Gerard Bilotto, Jonathan R. Lagarenne and Gerard P. Norton of New Jersey's Fox Rothschild give their take on the case.

By Shahnam Sharareh, Gerard Bilotto, Jonathan R. Lagarenne and Gerard P. Norton

5 minute read